Nav: Home

The deadly toxin acrolein has a useful biological role

June 01, 2016

Scientists from RIKEN in Japan have discovered that acrolein--a toxic substance produced in cells during times of oxidative stress--in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases. The key to this new role is a chemical process known as 4+4 cycloaddition, where two molecules with "backbones" made up of four-atom chains come together to form a ring-like structure with eight atoms. The group found that in some circumstances, acrolein can combine with a class of molecules called polyamines, which themselves are important biological players, to make substances that can prevent the fibrillation of Aβ40 peptides.

"What is remarkable," says Ayumi Tsutsui, the lead author of the paper published on June 1 in Advanced Science, "is that the reaction involves acrolein and a class of substances known as polyamines, which are all associated with oxidative stress. Polyamines are known to play very important biological roles, but the mechanisms are still poorly understood." Levels of acrolein have been found to correlate with the progression of diseases such as cancer and stroke. " According to Tamotsu Zako of Ehime University, who participated in the research, "It made sense to see acrolein simply as a dangerous substance that triggers disease, and many researchers saw it that way. But in our previous work we had discovered that acrolein could bind with polyamines such as spermine and spermidine to form eight-atom cyclic molecules, and we wondered what biological role these rings might play."

As the team began the experiments, they were surprised to find that these substances made from a combination of acrolein and the polyamines seemed to prevent the peptides known as amyloid-beta from aggregating together--a process linked to the progression of Alzheimer's disease, where neurons are gradually killed by the accumulation of these amyloid peptides.

The group tested the hypothesis by incubating A-beta40 peptides in mixtures of acrolein, a polyamine known as spermine, and a cyclic compound formed by acrolein and polyamines. Neither of the first two molecules alone had any effect on fibrillation, but the cyclic compounds turned out to be powerful inhibitors. The researchers also found that when acrolein and polyamines were added together into a living cell, they combined naturally through 4+4 cycloaddition to create the diazacylooctane molecule.

According to Katsunori Tanaka, who led the team, "This is important for several reasons. First, it gives us insights into the mechanism through which polyamines--which we know to be tremendously important biologically--exert their action. And secondly, because acrolein and polyamines combine naturally in cells to form these powerful anti-fibrillation substances, it may open the way for us to influence the progression of terrible neurological disorders such as Alzheimer's.

Tanaka said that in the current experiment the group used A-beta40, an amyloid peptide with 40 amino acids in the chain, but that they also hope in the future to conduct experiments with A-beta42, which is more prone to fibrillation and is also believed to play a key role in Alzheimer's disease.
-end-


RIKEN

Related Peptides Articles:

Designer peptides show potential for blocking viruses, encourage future study
Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges.
Tracking down cryptic peptides
Using a newly developed method, researchers from the University of Würzburg, in cooperation with the University Hospital of Würzburg, were able to identify thousands of special peptides on the surface of cells for the first time.
Synthesis of prebiotic peptides gives clues to the origin of life on Earth
Coordination Compounds Lab of Kazan Federal University started researching prebiotic peptide synthesis in 2013 with the use of the ASIA-330 flow chemistry system.
Peptides that can be taken as a pill
Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections to avoid degradation by stomach enzymes.
Harnessing psyllid peptides to fight citrus greening disease
BTI, USDA and UW scientists have identified peptides in the Asian citrus psyllid, an insect that spreads the bacterium that causes citrus greening disease (huanglongbing, HLB).
New technique has potential to protect oranges from citrus greening
Citrus greening, also called Huanglongbing (HLB), is devastating the citrus industry.
Researchers show what drives a novel, ordered assembly of alternating peptides
A team of researchers has verified that it is possible to engineer two-layered nanofibers consisting of an ordered row of alternating peptides, and has also determined what makes these peptides automatically assemble into this pattern.
Origin of life insight: peptides can form without amino acids
Peptides, one of the fundamental building blocks of life, can be formed from the primitive precursors of amino acids under conditions similar to those expected on the primordial Earth, finds a new UCL study published in Nature.
Ragon Institute study identifies viral peptides critical to natural HIV control
Investigators at the Ragon Institute of MGH, MIT and Harvard have used a novel approach to identify specific amino acids in the protein structure of HIV that appear critical to the ability of the virus to function and replicate.
Light and peptides: New method diversifies natural building blocks of life
EPFL chemists have developed a new, light-based method for modifying peptides at the C-terminal position.
More Peptides News and Peptides Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.